title: Medical management of side effects related to CAR T cell therapy in hematologic malignancies.
authors.affiliation: a Department of Pediatrics , Memorial Sloan Kettering Cancer Center , New York , NY , USA.
authors.forename: Manjusha
authors.initials: M
authors.lastname: Namuduri
authors.affiliation: b Department of Medicine , Memorial Sloan Kettering Cancer Center , New York , NY , USA.|c Center for Cell Engineering, Memorial Sloan Kettering Cancer Center , New York , NY , USA.|d Molecular Pharmacology & Chemistry Program , Memorial Sloan Kettering Cancer Center , New York , NY , USA.
authors.forename: Renier J
authors.initials: RJ
authors.lastname: Brentjens
mesh_terms: D018941:Antigens, CD19; D064987:Cell- and Tissue-Based Therapy; D019337:Hematologic Neoplasms; D006801:Humans; D016219:Immunotherapy, Adoptive; D011948:Receptors, Antigen, T-Cell
chemical_list: D018941:Antigens, CD19; D011948:Receptors, Antigen, T-Cell
keywords: CAR T cell; CD19; chimeric antigen receptor; cytokine release syndrome; immunotherapy